Healthy adults
Conditions
Interventions
Participants will intake one test beverages per day for twelve weeks. They will also get clinical tests before and 12 weeks after the beginning of the intervention.
Participants will intake one place
Sponsors
Allm Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Healthy Japanese men and women over 18 years old at the time of obtaining consent to participate in the study 2)Subjects who have given written consent(Consent to participate in MYCODE Research) to participate in MYCODE Research 3)Subjects who have be given sufficient explanation about the purpose and contents of this study, volunteer for voluntary participation with good understanding, and can consent to the study 4)Subjects who are aware of eye strain
Exclusion criteria
Exclusion criteria: 1)Subjects with a history of alcoholism or mental illness 2)Subjects with insomnia 3)Subjects who have a habit of intaking supplements to improve visual function 4)Subjects who are receiving continuous pharmaceutical treatment 5)Subjects with previous and/or current medical history of serious disease (e.g. liver, kidney, heart, lung, blood) 6)Females who are pregnant and/or lactating, or those with willingness/intention to become pregnant during the study 7)Subjects that plan to have irregular life cycle (e.g. midnight shift work, long-term travel) and/or those with extremely irregular dining and sleep habits 8)Subjects who have a habit of intaking lactic acid bacteria beverages 9)Subjects who have a habit of intaking Food for Specified Health Uses and/or Foods with Functional Claims 10)Subjects with current or past experience of participating in other clinical studies and/or subjects who plan to participate in other clinical trials after obtaining consent to participate in the study 11)Subjects with refractive errors that have not been properly corrected 12)Subjects who have severe astigmatism 13)Subjects who have undergone LASIK surgery in the past 14)Subjects who are judged by the principal investigator to be unsuitable as the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of eye focusing | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of visual acuity, flicker fusion frequency, and visual analogue scale score | — |
Countries
Japan
Contacts
Public ContactTakuya Tajima
Allm Inc. Medical DX Solutions Department
Outcome results
None listed